RCUS
Arcus Biosciences, Inc.
NYSE · Healthcare · Biotechnology · US
$29.66
−1.56%Leverage
- Debt / equity
- 0.25x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.27x
- Net debt / EBITDA
- 0.09x
Liquidity & coverage
- Current ratio
- 3.82x
- Quick ratio
- 3.82x
- Cash ratio
- 3.55x
- Interest coverage
- -21.13x
- EBITDA / interest
- -18.22x
- Working capital
- $558.0M
Cash & dividend
- FCF / debt
- -4.17x
- Cash flow / debt
- -4.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026